Dave Johnson, CEO of VelosBio, discusses how VelosBio is developing novel anti-body drug conjugates to target sold tumours.
Arix Bioscience is a healthcare and life science company that drives value in private and public companies through operational and strategic support and direction as well as patient capital.
Industry: Financial Services
Contact: +44 (0)20 7290 1050
20 Berkeley Square, London, W1J 6EQ, United Kingdom